Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines

References

• Infante-Cossio P, Torres-Carranza E, Cayuela A, Gutierrez-Perez JL, Gili-Miner M. Quality of life in patients with oral and oropharyngeal cancer. Int J Oral Maxillofac Surg 2009; 38:250-255; PMID:19135864; http://dx.doi.org/10.1016/j.ijom.2008.12.001
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110:1429-1435; PMID:17724670; http://dx.doi.org/10.1002/cncr.22963
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26:612-619; PMID:18235120; http://dx.doi.org/10.1200/JCO.2007.14.1713
   PubMed Web of Science ®Google Scholar
• Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105:175-201; PMID:23297039; http://dx.doi.org/10.1093/jnci/djs491
   PubMed Web of Science ®Google Scholar
• McIlwain WR, Sood AJ, Nguyen SA, Day TA. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 2014; 140:441-447; PMID:24652023; http://dx.doi.org/10.1001/jamaoto.2014.141
   PubMed Web of Science ®Google Scholar
• Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333:1154-1157; PMID:21798897; http://dx.doi.org/10.1126/science.1206923
   PubMed Web of Science ®Google Scholar
• Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333:1157-1160; PMID:21798893; http://dx.doi.org/10.1126/science.1208130
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35; PMID:20530316; http://dx.doi.org/10.1056/NEJMoa0912217
   PubMed Web of Science ®Google Scholar
• Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100:407-420; PMID:18334711; http://dx.doi.org/10.1093/jnci/djn025
   PubMed Web of Science ®Google Scholar
• D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199:1263-1269; http://dx.doi.org/10.1086/597755
   PubMed Web of Science ®Google Scholar
• D'Souza G, Cullen K, Bowie J, Thorpe, R, Fakhry C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 2014; 9:e86023; http://dx.doi.org/10.1371/journal.pone.0086023
   PubMed Web of Science ®Google Scholar
• Touyz LZ. Kissing and hpv: honest popular visions, the human papilloma virus, and cancers. Curr Oncol 2014; 21:e515-e517; PMID:24940111; http://dx.doi.org/10.3747/co.21.1970
   PubMed Web of Science ®Google Scholar
• Machtay M, Perch S, Markiewicz D, Thaler E, Chalian A, Goldberg A, Kligerman M, Weinstein G. Combined surgery and postoperative radiotherapy for carcinoma of the base of radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognostic value of margin status. Head Neck 1997; 19:494-499; PMID:9278757; http://dx.doi.org/10.1002/(SICI)1097-0347(199709)19:6<494::AID-HED6>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Denittis AS, Machtay M, Rosenthal DI, Sanfilippo NJ, Lee JH, Goldfeder S, Chalian AA, Weinstein GS, Weber RS. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol 2001; 22:329-335; PMID:11562884; http://dx.doi.org/10.1053/ajot.2001.26492
   PubMed Web of Science ®Google Scholar
• Machtay M, Rosenthal D, Hershock D, Jones H, Williamson S, Greenberg MJ, Weinstein GS, Aviles VM, Chalian AA, Weber RS. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. J Clin Oncol 2002; 20:3964-3971; PMID:12351593; http://dx.doi.org/10.1200/JCO.2002.11.026
   PubMed Web of Science ®Google Scholar
• Chen AY, Zhu J, Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009. Laryngoscope 2014; 124:131-138; PMID:23832649; http://dx.doi.org/10.1002/lary.24296
   PubMed Web of Science ®Google Scholar
• The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685-1690; PMID:2034244; http://dx.doi.org/10.1056/NEJM199106133242402
   PubMed Web of Science ®Google Scholar
• Irune E, Dwivedi RC, Nutting CM, Harrington KJ. Treatment-related dysgeusia in head and neck cancer patients. Cancer Treat Rev 2014; 40:1106-1117; PMID:25064135; http://dx.doi.org/10.1016/j.ctrv.2014.06.011
   PubMed Web of Science ®Google Scholar
• Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, et al. Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 2014; 111:281-288 .; PMID:24746582; http://dx.doi.org/10.1016/j.radonc.2014.02.019
   PubMed Web of Science ®Google Scholar
• Vatca M, Lucas JT Jr, Laudadio J, D'Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, et al. Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Oral Oncol 2014; 50:869-876; PMID:24998139; http://dx.doi.org/10.1016/j.oraloncology.2014.06.010
   PubMed Web of Science ®Google Scholar
• McBride SM, Parambi RJ, Jang JW, Goldsmith T, Busse PM, Chan AW. Intensity-modulated vs. conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes. Head Neck 2014; 36:492-498; PMID:23729221; http://dx.doi.org/10.1002/hed.23319
   PubMed Web of Science ®Google Scholar
• Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12:127-136; PMID:21236730; http://dx.doi.org/10.1016/S1470-2045(10)70290-4
   PubMed Web of Science ®Google Scholar
• Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, Rich JT, Milov S, Lewis JS Jr, Krishna M. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011; 33:1683-1694; PMID:21284056; http://dx.doi.org/10.1002/hed.21669
   PubMed Web of Science ®Google Scholar
• Choby GW, Kim J, Ling DC, Abberbock S, Mandal R, Kim S, Ferris RL, Duvvuri U. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. JAMA Otolaryngol Head Neck Surg 2015; 141:499-504; PMID:25834991; http://dx.doi.org/10.1001/jamaoto.2015.0347
   PubMed Web of Science ®Google Scholar
• Mercante G, Masiello A, Sperduti I, Cristalli G, Pellini R, Spriano G. Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery: A 1-year follow-up study. J Craniomaxillofac Surg 2015; 43:1561-1566;6; PMID:26197796
   PubMed Web of Science ®Google Scholar
• de Almeida JR, Moskowitz AJ, Miles BA, Goldstein DP, Teng MS, Sikora AG, Gupta V, Posner M, Genden EM. Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis. Head Neck 2014
   Web of Science ®Google Scholar
• Chen MM, Roman SA, Kraus DH, Sosa JA, Judson BL. Transoral Robotic Surgery: A Population-Level Analysis. Otolaryngol Head Neck Surg 2014; 150:968-975; PMID:24618503; http://dx.doi.org/10.1177/0194599814525747
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100:261-269; PMID:18270337; http://dx.doi.org/10.1093/jnci/djn011
   PubMed Web of Science ®Google Scholar
• O’Malley BWJ, Weinstein GS, Snyder W, Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116:1465-1472; http://dx.doi.org/10.1097/01.mlg.0000227184.90514.1a
   PubMed Web of Science ®Google Scholar
• Weinstein GS, O’Malley BWJ, Snyder W, Sherman E, Quon H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007; 133:1220-1226; PMID:18086963; http://dx.doi.org/10.1001/archotol.133.12.1220
   PubMed Web of Science ®Google Scholar
• Rich JT, Liu J, Haughey BH. Swallowing function after transoral laser microsurgery (TLM) +/− adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 2011; 121:2381-2390; PMID:21882203; http://dx.doi.org/10.1002/lary.21406
   PubMed Web of Science ®Google Scholar
• Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012; 30:6016-6019; PMID:22867718; http://dx.doi.org/10.1016/j.vaccine.2012.07.056
   PubMed Web of Science ®Google Scholar
• Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine 2010; 28:6858-6867; PMID:20713101; http://dx.doi.org/10.1016/j.vaccine.2010.08.030
   PubMed Web of Science ®Google Scholar
• Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 2004; 7:518-528; PMID:15367247; http://dx.doi.org/10.1111/j.1524-4733.2004.75003.x
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:630-632; PMID:20508594
   PubMedGoogle Scholar
• Lu PJ, Williams WW, Li J, Dorell C, Yankey D, Kepka D, Dunne EF. Human papillomavirus vaccine initiation and awareness: US young men in the 2010 National Health Interview Survey. Am J Prev Med 2013; 44:330-338; PMID:23498097; http://dx.doi.org/10.1016/j.amepre.2012.11.027
   PubMed Web of Science ®Google Scholar
• D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356:1944-1956; http://dx.doi.org/10.1056/NEJMoa065497
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 2013; 8:e68329; PMID:23873171; http://dx.doi.org/10.1371/journal.pone.0068329
   PubMed Web of Science ®Google Scholar
• Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:784-792; PMID:26225476; http://dx.doi.org/10.15585/mmwr.mm6429a3
   PubMed Web of Science ®Google Scholar
• Luryi AL, Yarbrough WG, Niccolai LM, Roser S, Reed SG, Nathan CA, Moore MG, Day T, Judson BL. Public awareness of head and neck cancers: a cross-sectional survey. JAMA Otolaryngol Head Neck Surg 2014; 140:639-646; PMID:24902640; http://dx.doi.org/10.1001/jamaoto.2014.867
   PubMed Web of Science ®Google Scholar
• Kram YA, Schmidt TH, Saghezchi S, Russell MD. Attitudes toward Human Papilloma Virus Vaccination and Head and Neck Cancer Prevention in a Diverse, Urban Population. Otolaryngol Head Neck Surg 2015; 153:538-543. PMID: 25779468
   Web of Science ®Google Scholar
• McRee AL, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Biomarkers Prev 2010; 19:1937-1944; PMID:20647398; http://dx.doi.org/10.1158/1055-9965.EPI-09-1287
   PubMed Web of Science ®Google Scholar
• Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010; 126:425-433; PMID:20679306; http://dx.doi.org/10.1542/peds.2009-3500
   PubMed Web of Science ®Google Scholar